Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | P10 |
| Synonyms | |
| Therapy Description |
P10 is a pyridazine derivative that inhibits PARP1 activity, which may result in inhibition of cell proliferation and cell-cycle arrest and leads to enhanced activity when combined with an HDAC inhibitor (PMID: 27188390). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| P10 | PARP-1 Inhibitor 13 | P10 is a pyridazine derivative that inhibits PARP1 activity, which may result in inhibition of cell proliferation and cell-cycle arrest and leads to enhanced activity when combined with an HDAC inhibitor (PMID: 27188390). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|